AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUN 182 min read$BCYC

BICYCLE THERAPEUTICS PLC (BCYC): Submission of Matters to a Vote of Security Holders

BICYCLE THERAPEUTICS PLC (BCYC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001761612 X0 00-0000000 true 0001761612 2026-06-17 2026-06-17 0001761612 us-gaap:CommonStockMember 2026-06-17 2026-06-17 0001761612 bcyc:AmericanDepositarySharesMember 2026-06-17 2026-06-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCH

Original reporting
SEC EDGAR 8-K
Published Jun 18, 2026, 12:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 12:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$BCYC
Neutral
high confidence
Mentioned
$BCYC
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BCYCNeutralLow
01

Why it matters

The disclosed items were director re-elections, an advisory say-on-pay proposal, and ratification/re-appointment of PricewaterhouseCoopers LLP as auditors, all described as duly passed.

02

Market read

This is a routine governance disclosure with no new clinical, financial, or regulatory information; trading impact should be limited.

03

What to watch

The document references the April 22, 2026 definitive proxy statement for detailed proposals; any real signal would likely be in that proxy, not in the vote tally itself.

Relevance 6/10Novelty 2/10Timing: filed June 18, 2026 after June 17 AGM vote results

Background

The filing is an SEC Form 8-K under Item 5.07 reporting matters submitted to a vote of security holders at Bicycle Therapeutics’ June 17, 2026 AGM.

Company-level read

Ticker impact

$BCYCNeutralHigh confidence
Context

Bicycle Therapeutics reported AGM voting results on June 17, 2026, including director re-elections and auditor ratification under Item 5.07.

Expected impact

Limited near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The 8-K is a standard Item 5.07 disclosure of votes passed, with no changes to guidance, trials, financing, or enforcement actions.

Market effects

Sector

No sector read-across; governance-only filing for a biotech issuer.

Regional

Minimal; US-listed ADS governance disclosure.

Global

Minimal; UK-incorporated company’s routine AGM results.

Counterpoint

What could challenge this read

If investors were expecting a contested vote or auditor change, the clear “passed” outcomes could reduce uncertainty, but the filing still lacks new fundamentals.

Key entities

  • issuer
    Bicycle Therapeutics plc

    Company reporting AGM voting results on June 17, 2026 via Item 5.07 of Form 8-K.

  • auditor
    PricewaterhouseCoopers LLP

    Independent registered public accounting firm and UK statutory auditor ratified/re-appointed for 2026.

  • director
    Felix Baker

    Re-elected as a director (Proposal 1).

  • director
    Hervé Hoppenot

    Re-elected as a director (Proposal 2).

Read at source← All news

Related articles

JUL 30
$BCYCMed

Bicycle Therapeutics plc: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Bicycle Therapeutics (NASDAQ: BCYC) reported Q2 2026 results and business updates. It cited AACR/ASCO data for nuzefatide in EphA2-expressing cancers, including Phase 2 recurrent pancreatic cancer with first patient dosed in April 2026. Cash was $510.1M at June 30, 2026, funding into 2030. Duravelo-2 interim Week 27 ORR was 65% (17/26).

finanznachrichten.de6 min
JUL 30
$BCYCMed

BICYCLE THERAPEUTICS PLC (BCYC): Results of Operations and Financial Condition

BICYCLE THERAPEUTICS PLC (BCYC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2621593d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results Data presented at AACR and ASCO provide further validation of the potential of Bicycle ® technology to deliver oncology thera

SEC EDGAR 8-K6 min
AUG 9
$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

yahoo.com6 min
AUG 9
$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

rttnews.com2 min
AUG 9
$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

rte.ie6 min
AUG 9
$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

yahoo.com6 min